Doctors

Here, Dr. Michelle Weiner shares her journey to learning and practicing cannabis medicine.

Dr. Woody, chief executive officer of 180 Life Sciences, discusses in this interview the current research surrounding synthetic cannabinoids as a treatment for chronic pain, as well as the development of a new type of medication that would have the potential to offer the benefits of cannabis without any undesirable effects.

Peter Grinspoon, MD, a primary care physician at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School, shares his knowledge on medical cannabis, issues facing the industry, and hopes for the future.

Dr. Marissa Weiss offers some tips and talking points to help patients start a conversation about the therapeutic use of cannabis for breast cancer.

In this roundtable interview series, we speak to the organizers of the CannMed Medical Practicum—Bonni Goldstein, MD; Dustin Sulak, DO; Kevin Spelman, PhD, MCPP; and Eloise Theisen, NP, AGPCNP-BC— to learn more about them and what attendees can expect from the practicum. Here in part III, they discuss how cannabis is used to treat acute and chronic pain, anxiety, ADHD, and pediatric patients.

Dr. Bonni Goldstein discusses her observations about how cannabis can “move the brain forward,” explaining how she has seen it help some of her worst seizure disorder patients who had severe developmental delays begin to advance developmentally while using cannabis medicine.

As successful owners of the medical cannabis dispensary Greenhouse Wellness, Gina Dubbé and OBGYN Dr. Leslie Apgar share their history and future plans.

Dr. Julie Hildebrand, Dr. Peter Blecher, and a medical cannabis patient share their insight into medical cannabis as a treatment for pain management in Canada through the help of WeedMD and others.

Dr. Sue Sisley has been pioneering research in the U.S. cannabis industry and fighting for quality cannabis samples to conduct her clinical trials. We recently spoke to her about the challenges she’s faced, what’s ahead for her future research, and more.

David L. Nathan, MD, DFAPA, President, Board of Directors, Doctors for Cannabis Regulations (DFCR), discusses how the DFCR was formed, the efforts they have been making in the cannabis field, and plans for the future of the organization.